Navigation Links
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
Date:7/22/2014

hich has been filed for regulatory approvals in the U.S., Europe and Canada as a once- daily, oral tablet for the treatment of opioid-induced constipation. This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid. NKTR-181, a novel mu-opioid analgesic molecule for chronic pain conditions, has completed Phase 2 development. NKTR-171, a new sodium channel blocker being developed as an oral therapy for the treatment of peripheral neuropathic pain, is in Phase 1 clinical development. In oncology, etirinotecan pegol (NKTR-102) is being evaluated in a Phase 3 clinical study (the BEACON study) for the treatment of metastatic breast cancer and is also in Phase 2 studies for the treatment of lung and brain cancers. In anti-infectives, Amikacin Inhale is in Phase 3 studies conducted by Bayer Healthcare as an adjunctive treatment for intubated and mechanically ventilated patients with Gram-negative pneumonia. Additional late-stage development products that leverage Nektar's proprietary technology platform include Baxter's BAX 855, a longer-acting rFVIII program, which is in Phase 3 clinical development for patients with hemophilia A.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
2. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
3. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
4. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
6. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
7. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
8. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
9. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
10. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the Jefferies 2013 Global Healthcare Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)...  SillaJen, Inc., a private clinical-stage biotherapeutics company ... for cancer, today announced an oral and poster ... the American Association for Cancer Research (AACR) demonstrating ... its lead product candidate, Pexa-Vec (JX-594) with angiogenesis ... designed to 1) rapidly de-bulk tumors via tumor ...
(Date:4/20/2015)... 20, 2015 The global orthopedic ... the concerned global with analysis and forecast of revenue. ... is estimated to reach $4,918.7 million by 2019, at ... Browse through the TOC of global orthopedic braces ... the industry trends and segments, with help of various ...
(Date:4/20/2015)... , April 20, 2015  Teradata (NYSE: ... and marketing applications company, today ... The Teradata Analytics Framework for Life Sciences helps ... as Research and Early Discovery (RED), clinical analysis, ... from multiple, relevant sources, companies can benefit by ...
Breaking Medicine Technology:SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 2Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 3Teradata Delivers Big Analytics Innovation for Life Sciences 2Teradata Delivers Big Analytics Innovation for Life Sciences 3Teradata Delivers Big Analytics Innovation for Life Sciences 4
... LUTHERVILLE, Md., Dec. 14, 2011  The National ... a nonprofit organization that facilitates cooperation between ... and pharmaceutical manufacturers in the prevention and ... data showing the National Precursor Log Exchange ...
... Dec. 14, 2011  Heska Corporation (NASDAQ: HSKA ... diagnostic and specialty products to veterinarians, announced today the ... core expertise in blood-related disorders.  The parties are to ... blood cell-based therapeutics, for use in the veterinary market.  ...
Cached Medicine Technology:Indiana Stop-Sale System Shows Effectiveness of Real-Time, Blocking Technology in the Fight Against Illegal Sales of Pseudoephedrine 2Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc. 2Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc. 3
(Date:4/21/2015)... Pharmacy point of sale software ... Pharmacy Cooperative trade show, to be held April 30 ... Retail Management Solutions recently became an approved vendor with ... VP of Sales and Marketing. Gross says that IPC ... shows in the country -- and this new partnership ...
(Date:4/21/2015)... Lifeguard Master is out with their new spider ... on the Lifeguard Master website and are in stock. The ... a quality and flexible product during their rescue efforts. According ... Spider Straps are some of the most popular items we ... heavy nylon” , The Spider Straps are rated superior to ...
(Date:4/21/2015)... Rafael, CA (PRWEB) April 21, 2015 ... players at the beautiful Governor’s Academy prep school in ... running July 10-12, 2015, for boys entering grades 6-12. ... compliment and supplement the players’ fall coaching. ... skilled athletes. Not only are these the most unsung ...
(Date:4/21/2015)... 21, 2015 Renewable energy, sustainable living, ... of the Earth Day topics USM Studios ’ ... leaders debate the affect of climate change on the ... subject matter touching on the environmental concerns affecting the ... delve into sustainable lifestyles, clean air options, and much ...
(Date:4/21/2015)... 21, 2015 Spring and summer are ... people visiting family for the holidays or simply taking ... planning to travel can be a difficult choice. Pet-friendly ... with pets is becoming a more common option. ... a stay at pet-friendly accommodations a positive experience. , ...
Breaking Medicine News(10 mins):Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 2Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 2Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 3Health News:New Spider Straps for Spine Boards are Introduced for Easy, Fast, and Convenient Use 4Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4
... open between the Polish government and striking nurses who have ... the past week, a union official said Tuesday . ... in support of their campaign for better pay left Tuesday ... Dorota Gardias, head of the OZZPP national nurses' union. ...
... has a great relationship with wine, after being hooked to the ... said that she loves 'European and all different types of wine', ... ,"We have been together for about 10 years now, and ... like European and all different types. We are very happy together," ...
... grown by Prince Charles, because they were found to be ... rejection of the vegetable, which Prince Charles sells under his ... revealed the Prince of Wales is investing more than ever ... accounts published by Clarence House show the Prince received a ...
... Sheriff Lee Baca, who placed hotel heiress Paris Hilton ... that the socialite was suffering from a 'life-threatening' ... condition is the deterioration of one's mental state to ... ,Baca also said that the Simple Life star's ...
... among prisoners than among the general population of Thailandone study, ... that 25% of prisoners who agreed to be tested were ... the national population. ,But Thailands prisons, say Ford ... severe budgetary constraints that impede the effective delivery of HIV ...
... her recent weight loss. ,The actress, who ... recent public appearances, admitted that she has become too thin. ... weight loss is a result of stress following her mother's ... I lost my mom and I've gone through a lot," ...
Cached Medicine News:
... to use and transportable, the Dornier Compact Delta ... user and the patient. The systems shock source ... zone accuracy and avoid the risk of misalignment. ... unique due to its motorized lateral and horizontal ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
Medicine Products: